Medicine Platform

Resmetirom

  • 收藏 0

Price

  • 面议

CHENGHUI PHARMACEUTICAL GROUP LTD
+86-531-58897070
  • 发货地  
  • 品 牌  CHENGHUI PHARMACEUTICAL GROUP LTD
本公司精品橱窗推荐
  • 模式:制造商,其他机构
  • 资本:9999万人民币
  • 类型:企业单位(制造商,其他机构)
  • 主营:xiehuihui
  • 地区:
本页信息为CHENGHUI PHARMACEUTICAL GROUP LTD为您提供的“Resmetirom”产品信息,如您想了解更多关于“Resmetirom”价格、型号、厂家,请联系厂家,或给厂家留言。
询价 暂无
发货
品牌 CHENGHUI PHARMACEUTICAL GROUP LTD
过期 长期有效
更新 2025-08-14 02:31

Resmetirom

Grade: Pharmaceutical Grade

Factory Location: Shandong China

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Middle East,Africa

Contract Manufacturing: CMO

Packaging Information: 5g;10g;100g

Sample Provided: yes

Payment Terms: L/C

Product Details
Product name: RESMETIROM MGL-3196

English alias:

Resmetirom; MGL-3196; 920509-32-6; VIA-3196; 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-dioxo-2,3 ,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile; MGL 3196; Resmetirom [USAN]; MGL3196; RE0V0T1ES0

CAS No. 920509-32-6

Molecular Formula: C17H12Cl2N6O4

Molecular weight: 435.22

EINECS number:

Density: 1.65±0.1g/cm3(Predicted)

Storage condition: Inertatmosphere,Storeinfreezer,under-20°C

Solubility: DMSO: 59.0 (maximum concentration mg/mL); 135.56 (maximum concentration mM)

Form: Crystalline solid

Acidity coefficient: (pKa)3.96±0.40(Predicted)

Characteristics: light yellow solid powder

Product Use: BioactivityResmetirom (MGL-3196,VIA-3196) is a hepatic-directed, orally active, selective thyroidhormonereceptorβ(THR-β) agonist with an EC50 of 0.21 μM and a 28-fold selectivity for THR-β over THR-α.

MGL-3196 has been tested for the treatment of non-alcoholic steatohepatitis and heterozygous familial hypercholesterolemia.

Product specification: 1kg/barrel, 2kg/barrel, 5kg/barrel, 10kg/barrel, 15kg/barrel, 20kg/barrel, 25kg/barrel, etc., and can be separately subcontracted according to customers' requirements.

Price: Price is for reference only, call us for one-to-one quotation.

 

MGL-3196 Upstream and downstream product information
Upstream products: 4-(Propan-2-yl)pyridazine-3,6-diol

3,6-dichloro-4-isopropylpyridazine; 3,6-dichloro-4-isopropylpyridazine

 6-(4-Amino-2,6-dichlorophenoxy)-4-isopropylpyridazin-3(2H)-one

 

 

 Advantageous products
Main products: Vonorazan fumarate and intermediates, Dagliflozin and intermediates, Clevoborol and intermediates, Letemovir and intermediates, Mildronate, veterinary products (intermediates of floretanol, aflatanol and sarolanol, etc.), ropivacaine hydrochloride and intermediates, local anesthesia series (Lidocaine Hydrochloride, Lidocaine, Propamocaine Hydrochloride, Propovacaine Hydrochloride, Butocaine Hydrochloride, etc.), covering local anesthesia, local anesthesia drugs, and the intermediates. Our products cover the fields of local anesthetics, antiviral drugs, cardiovascular and cerebrovascular drugs, antitumor drugs, digestive drugs, diabetes drugs, veterinary drugs and so on. Our main advantages are high quality products, reasonable price, fast delivery and considerate after-sales service, and we support customized products.

公司名 CHENGHUI PHARMACEUTICAL GROUP LTD 经营模式制造商,其他机构
注册资本9999万人民币 公司注册时间2008年
公司所在地 企业类型企业单位 (制造商,其他机构)
主营行业 Medical Software
主营产品或服务xiehuihui
联系方式
Medicine Platform
全网同类推荐
 
Disclaimer:
当前页为价格信息展示,该页所展示的批发价格、报价等相关信息均有企业自行提供,价格真实性、准确性、合法性由店铺所有企业完全负责。Medicine Platform对此不承担任何保证责任。
Reminder:
建议您通过拨打厂家联系方式确认最终价格,并索要样品确认产品质量。如报价过低,可能为虚假信息,请确认报价真实性,谨防上当受骗。